» Articles » PMID: 8648669

Serine 3 is Critical for Phosphorylation at the N-terminal End of the Nucleoprotein of Influenza Virus A/Victoria/3/75

Overview
Journal J Virol
Date 1996 Jun 1
PMID 8648669
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

The influenza A virus nucleoprotein (NP) is a phosphoprotein that encapsidates the viral genomic RNA. To map the in vivo phosphorylation site(s) of this protein, 32P-labeled NP was purified from cell cultures infected with influenza virus A/Victoria/3/75 by immunoaffinity chromatography. The purified protein was then subjected to chemical digestion with formic acid, which cleaves proteins at Asp-Pro bonds, and the resulting products were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Two of the phosphorylated products obtained were identified as fragments corresponding to the N-terminal 88 amino acids and to the C-terminal 196 residues of the NP. To identify the phosphate acceptor site(s) at the N-terminal phosphorylated region of NP, each of the seven serines within this region was individually changed to alanine by site-directed mutagenesis. The mutant proteins were then transiently expressed in mammalian cells and analyzed for their phosphorylation state. It was observed that the S-to-A mutation at position 3 drastically reduced the amount of 32P label incorporated into NP, whereas the other substitutions did not have a discernible effect on the phosphorylation level of the protein. In addition, all serine-altered proteins were tested for their functionality in an artificial system in which expression of a synthetic chloramphenicol acetyl-transferase RNA molecule is driven by influenza virus proteins synthesized from cloned genes. The results obtained demonstrate that all mutant proteins were competent to cooperate with the subunits of the viral polymerase for expression of the synthetic virus-like chloramphenicol acetyltransferase RNA in vivo. These data are discussed regarding the possible roles of NP phosphorylation for the viral replicative cycle.

Citing Articles

FDA-approved Abl/EGFR/PDGFR kinase inhibitors show potent efficacy against pandemic and seasonal influenza A virus infections of human lung explants.

Meineke R, Stelz S, Busch M, Werlein C, Kuhnel M, Jonigk D iScience. 2023; 26(4):106309.

PMID: 36968089 PMC: 10034449. DOI: 10.1016/j.isci.2023.106309.


FDA-Approved Inhibitors of RTK/Raf Signaling Potently Impair Multiple Steps of In Vitro and Ex Vivo Influenza A Virus Infections.

Meineke R, Stelz S, Busch M, Werlein C, Kuhnel M, Jonigk D Viruses. 2022; 14(9).

PMID: 36146864 PMC: 9504178. DOI: 10.3390/v14092058.


Influenza Virus Infections and Cellular Kinases.

Meineke R, Rimmelzwaan G, Elbahesh H Viruses. 2019; 11(2).

PMID: 30791550 PMC: 6410056. DOI: 10.3390/v11020171.


hCLE/C14orf166, a cellular protein required for viral replication, is incorporated into influenza virus particles.

Rodriguez-Frandsen A, de Lucas S, Perez-Gonzalez A, Perez-Cidoncha M, Roldan-Gomendio A, Pazo A Sci Rep. 2016; 6:20744.

PMID: 26864902 PMC: 4749964. DOI: 10.1038/srep20744.


Phosphorylation of Single Stranded RNA Virus Proteins and Potential for Novel Therapeutic Strategies.

Keck F, Ataey P, Amaya M, Bailey C, Narayanan A Viruses. 2015; 7(10):5257-73.

PMID: 26473910 PMC: 4632380. DOI: 10.3390/v7102872.


References
1.
Martin K, Helenius A . Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import. Cell. 1991; 67(1):117-30. DOI: 10.1016/0092-8674(91)90576-k. View

2.
Kobayashi M, Toyoda T, Adyshev D, Azuma Y, Ishihama A . Molecular dissection of influenza virus nucleoprotein: deletion mapping of the RNA binding domain. J Virol. 1994; 68(12):8433-6. PMC: 237318. DOI: 10.1128/JVI.68.12.8433-8436.1994. View

3.
Almond J, Felsenreich V . Phosphorylation of the nucleoprotein of an avian influenza virus. J Gen Virol. 1982; 60(Pt 2):295-305. DOI: 10.1099/0022-1317-60-2-295. View

4.
Albo C, Valencia A, Portela A . Identification of an RNA binding region within the N-terminal third of the influenza A virus nucleoprotein. J Virol. 1995; 69(6):3799-806. PMC: 189097. DOI: 10.1128/JVI.69.6.3799-3806.1995. View

5.
de la Luna S, Martinez C, Ortin J . Molecular cloning and sequencing of influenza virus A/Victoria/3/75 polymerase genes: sequence evolution and prediction of possible functional domains. Virus Res. 1989; 13(2):143-55. DOI: 10.1016/0168-1702(89)90012-9. View